Literature DB >> 20054645

Estimation of natural history parameters of breast cancer based on non-randomized organized screening data: subsidiary analysis of effects of inter-screening interval, sensitivity, and attendance rate on reduction of advanced cancer.

Jenny Chia-Yun Wu1, Matti Hakama, Ahti Anttila, Amy Ming-Fang Yen, Nea Malila, Tytti Sarkeala, Anssi Auvinen, Sherry Yueh-Hsia Chiu, Hsiu-Hsi Chen.   

Abstract

Estimating the natural history parameters of breast cancer not only elucidates the disease progression but also make contributions to assessing the impact of inter-screening interval, sensitivity, and attendance rate on reducing advanced breast cancer. We applied three-state and five-state Markov models to data on a two-yearly routine mammography screening in Finland between 1988 and 2000. The mean sojourn time (MST) was computed from estimated transition parameters. Computer simulation was implemented to examine the effect of inter-screening interval, sensitivity, and attendance rate on reducing advanced breast cancers. In three-state model, the MST was 2.02 years, and the sensitivity for detecting preclinical breast cancer was 84.83%. In five-state model, the MST was 2.21 years for localized tumor and 0.82 year for non-localized tumor. Annual, biennial, and triennial screening programs can reduce 53, 37, and 28% of advanced cancer. The effectiveness of intensive screening with poor attendance is the same as that of infrequent screening with high attendance rate. We demonstrated how to estimate the natural history parameters using a service screening program and applied these parameters to assess the impact of inter-screening interval, sensitivity, and attendance rate on reducing advanced cancer. The proposed method makes contribution to further cost-effectiveness analysis. However, these findings had better be validated by using a further long-term follow-up data.

Entities:  

Mesh:

Year:  2010        PMID: 20054645     DOI: 10.1007/s10549-009-0701-x

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  5 in total

1.  Sensitivity and specificity of mammographic screening as practised in Vermont and Norway.

Authors:  S Hofvind; B M Geller; J Skelly; P M Vacek
Journal:  Br J Radiol       Date:  2012-09-19       Impact factor: 3.039

2.  Overdiagnosis due to breast cancer screening: updated estimates of the Helsinki service study in Finland.

Authors:  S Heinävaara; T Sarkeala; A Anttila
Journal:  Br J Cancer       Date:  2014-08-14       Impact factor: 7.640

3.  A pre-symptomatic incubation model for precision strategies of screening, quarantine, and isolation based on imported COVID-19 cases in Taiwan.

Authors:  Grace Hsiao-Hsuan Jen; Amy Ming-Fang Yen; Chen-Yang Hsu; Sam Li-Sheng Chen; Tony Hsiu-Hsi Chen
Journal:  Sci Rep       Date:  2022-04-11       Impact factor: 4.379

4.  Time trends in breast cancer incidence and mortality in a mid-sized northeastern Brazilian city.

Authors:  Carlos Anselmo Lima; Margareth Rose Uchoa Rangel; Matheus Macedo-Lima; Angela Maria da Silva
Journal:  BMC Public Health       Date:  2012-10-19       Impact factor: 3.295

5.  Quantifying the natural history of breast cancer.

Authors:  K H X Tan; L Simonella; H L Wee; A Roellin; Y-W Lim; W-Y Lim; K S Chia; M Hartman; A R Cook
Journal:  Br J Cancer       Date:  2013-10-01       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.